High Frequency of a Retinoid X Receptor &ggr; Gene Variant in Familial Combined Hyperlipidemia That Associates With Atherogenic Dyslipidemia

Objective—The genetic background of familial combined hyperlipidemia (FCHL) has not been fully clarified. Because several nuclear receptors play pivotal roles in lipid metabolism, we tested the hypothesis that genetic variants of nuclear receptors contribute to FCHL. Methods and Results—We screened all the coding regions of the PPAR&agr;, PPAR&ggr;2, PPAR&dgr;, FXR, LXR&agr;, and RXR&ggr; genes in 180 hyperlipidemic patients including 60 FCHL probands. Clinical characteristics of the identified variants were evaluated in other 175 patients suspected of coronary disease. We identified PPAR&agr; Asp140Asn and Gly395Glu, PPAR&ggr;2 Pro12Ala, RXR&ggr; Gly14Ser, and FXR −1g−>t variants. Only RXR&ggr; Ser14 was more frequent in FCHL (15%, P<0.05) than in other primary hyperlipidemia (4%) and in controls (5%). Among patients suspected of coronary disease, we identified 9 RXR&ggr; Ser14 carriers, who showed increased triglycerides (1.62±0.82 versus 1.91±0.42 [mean±SD] mmol/L, P<0.05), decreased HDL-cholesterol (1.32±0.41 versus 1.04±0.26, P<0.05), and decreased post-heparin plasma lipoprotein lipase protein levels (222±85 versus 149±38 ng/mL, P<0.01). In vitro, RXR&ggr; Ser14 showed significantly stronger repression of the lipoprotein lipase promoter than RXR&ggr; Gly14. Conclusion—These findings suggest that RXR&ggr; contributes to the genetic background of FCHL.

[1]  A. Gotto,et al.  High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. , 1987, The Journal of clinical investigation.

[2]  N. Day,et al.  Serum Lipoprotein Lipase Concentration and Risk for Future Coronary Artery Disease: The EPIC-Norfolk Prospective Population Study , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[3]  K. Shirai,et al.  Lipoprotein lipase mass and activity in severe hypertriglyceridemia. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[4]  Winston Chu,et al.  Mutation screening and association of human retinoid X receptor gamma variation with lipid levels in familial type 2 diabetes. , 2002, Molecular genetics and metabolism.

[5]  P. Chambon,et al.  Functional role of RXRs and PPARγ in mature adipocytes , 2005 .

[6]  Joseph L. Goldstein,et al.  Hyperlipidemia in Coronary Heart Disease , 1973 .

[7]  P. Wilson,et al.  Association Between the PPARA L162V Polymorphism and Plasma Lipid Levels: The Framingham Offspring Study , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[8]  W. Brown,et al.  A new method for the measurement of lipoprotein lipase in postheparin plasma using sodium dodecyl sulfate for the inactivation of hepatic triglyceride lipase. , 1979, Journal of lipid research.

[9]  Robert A Hegele,et al.  Retinoid X receptor heterodimers in the metabolic syndrome. , 2005, The New England journal of medicine.

[10]  Päivi Pajukanta,et al.  Familial Combined Hyperlipidemia in Mexicans: Association With Upstream Transcription Factor 1 and Linkage on Chromosome 16q24.1 , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[11]  H. Coon,et al.  Replication of Linkage of Familial Combined Hyperlipidemia to Chromosome 1q With Additional Heterogeneous Effect of Apolipoprotein A-I/C-III/A-IV Locus: The NHLBI Family Heart Study , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[12]  M. Arcà,et al.  Familial combined hyperlipoproteinemia: experts panel position on diagnostic criteria for clinical practice. Committee of experts of the Atherosclerosis and Dysmetabolic Disorders Study Group. , 1999, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[13]  R. Eckel,et al.  Thyroid hormone resistance and increased metabolic rate in the RXR-gamma-deficient mouse. , 2000, The Journal of clinical investigation.

[14]  L. Hamann,et al.  Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists , 1997, Nature.

[15]  B. Staels,et al.  The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[16]  A. Aro,et al.  Family study of serum lipids and lipoproteins in coronary heart-disease. , 1973, Lancet.

[17]  M. Ng,et al.  The linkage and association of the gene encoding upstream stimulatory factor 1 with type 2 diabetes and metabolic syndrome in the Chinese population , 2005, Diabetologia.

[18]  H. Snieder,et al.  Gender-related association between the -93T-->G/D9N haplotype of the lipoprotein lipase gene and elevated lipid levels in familial combined hyperlipidemia. , 1998, Atherosclerosis.

[19]  P Chambon,et al.  RXR gamma null mice are apparently normal and compound RXR alpha +/-/RXR beta -/-/RXR gamma -/- mutant mice are viable. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  H. Lithell,et al.  Plasma fat elimination tissue lipoprotein lipase activity and plasma fatty acid composition during sequential treatment with etretinate and isotretinoin. , 1987, Acta dermato-venereologica.

[21]  Andreas Busjahn,et al.  Support for linkage of familial combined hyperlipidemia to chromosome 1q21–q23 in Chinese and German families , 2000, Clinical genetics.

[22]  K. Nakajima,et al.  Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[23]  H. Mabuchi,et al.  Development of coronary heart disease in familial hypercholesterolemia. , 1989, Circulation.

[24]  R. Eckel,et al.  Retinoid X receptor gamma-deficient mice have increased skeletal muscle lipoprotein lipase activity and less weight gain when fed a high-fat diet. , 2004, Endocrinology.

[25]  M. Leppert,et al.  A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. , 1999, Diabetes.

[26]  M. Grompe,et al.  The rapid detection of unknown mutations in nucleic acids , 1993, Nature genetics.

[27]  A. Motulsky,et al.  Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. , 1973, The Journal of clinical investigation.

[28]  H. Coon,et al.  Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides , 2005, Human Genetics.

[29]  H. Mabuchi,et al.  Enzyme immunoassay for cholesteryl ester transfer protein in human serum. , 1998, Clinica chimica acta; international journal of clinical chemistry.

[30]  R. Evans,et al.  The RXR heterodimers and orphan receptors , 1995, Cell.

[31]  P. D. de Jong,et al.  Positional cloning of the combined hyperlipidemia gene Hyplip1 , 2002, Nature genetics.

[32]  S. Grundy,et al.  Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[33]  H. Naito,et al.  Measurement of total HDL, HDL2 and HDL3 by dextran sulfate-MgCl2 precipitation technique in human serum. , 1986, Clinica chimica acta; international journal of clinical chemistry.

[34]  H. Blom,et al.  Thioredoxin interacting protein in Dutch families with familial combined hyperlipidemia , 2004, American journal of medical genetics. Part A.

[35]  L. Peltonen,et al.  Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1) , 2004, Nature Genetics.

[36]  R. Eckel,et al.  Retinoid X Receptor γ-Deficient Mice Have Increased Skeletal Muscle Lipoprotein Lipase Activity and Less Weight Gain when Fed a High-Fat Diet , 2004 .

[37]  B. Müller-Myhsok,et al.  Peroxisome proliferator-activated receptor gamma gene locus is related to body mass index and lipid values in healthy nonobese subjects. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[38]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[39]  P. Froguel,et al.  Common polymorphisms in the USF1 gene are not associated with type 2 diabetes in French Caucasians. , 2005, Diabetes.

[40]  M. Stumvoll,et al.  The Peroxisome Proliferator-Activated Receptor-γ2 Pro12Ala Polymorphism , 2002 .

[41]  J. Haft,et al.  Inheritance of combined hyperlipoproteinemia: evidence for a new lipoprotein phenotype. , 1973, The American journal of medicine.

[42]  P. Chambon,et al.  Functional role of RXRs and PPARgamma in mature adipocytes. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[43]  P. de Knijff,et al.  The lipoprotein lipase (Asn291-->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia. , 1996, Atherosclerosis.

[44]  J. Hendriks,et al.  Diagnosis of Familial Combined Hyperlipidemia Based on Lipid Phenotype Expression in 32 Families: Results of a 5-Year Follow-Up Study , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[45]  G. Muscat,et al.  Characterization of the AB (AF-1) region in the muscle-specific retinoid X receptor-gamma: evidence that the AF-1 region functions in a cell-specific manner. , 1996, Nucleic acids research.

[46]  R. Eckel,et al.  Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activity. , 2001, Molecular pharmacology.

[47]  D. Tregouet,et al.  Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II. , 2004, Human molecular genetics.

[48]  T. Lehtimäki,et al.  Linkage of familial combined hyperlipidaemia to chromosome 1q21–q23 , 1998, Nature Genetics.

[49]  P. Talmud,et al.  Variation in the PPARα gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects , 2000, Diabetologia.

[50]  T. Kawada,et al.  Retinoic acid receptor γ 2 gene expression is up-regulated by retinoic acid in 3T3-L1 preadipocytes , 1993 .

[51]  R. Eckel,et al.  Thyroid hormone resistance and increased metabolic rate in the RXR-γ–deficient mouse , 2000 .

[52]  Philippe Froguel,et al.  Variation Within the Gene Encoding the Upstream Stimulatory Factor 1 Does Not Influence Susceptibility to Type 2 Diabetes in Samples From Populations With Replicated Evidence of Linkage to Chromosome 1q , 2006, Diabetes.